TABLE 3.
Medications |
Pre-admission (n=310) |
First 24 h of admission (n=503) |
At discharge (n=310) |
|||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Beta-agonist bronchodilators | ||||||
Short-acting | 164 | 53 | 476 | 95 | 195 | 63 |
Long-acting | 18 | 6 | 11 | 2 | 9 | 3 |
Anticholinergic bronchodilators | 168 | 54 | 447 | 89 | 175 | 57 |
Inhaled corticosteroids | 139 | 45 | 174 | 35 | 120 | 39 |
Parenteral corticosteroids | – | 81 | 16 | – | ||
Oral corticosteroids | 64 | 21 | 214 | 43 | 154 | 50 |
Antibiotics | 71 | 23 | 329 | 66 | 134 | 37 |
Combination inhalers | 39 | 13 | 6 | 1 | 24 | 8 |
Note: The percentage of medication used in the preadmission and discharge columns was based on the number of patients (n=310), while to follow the use of medication in patients with several readmissions during the study period, the percentage of medication use in the ‘first 24 hours of admission’ was based on the total number of admissions (n=503)